Literature DB >> 34670809

Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis.

Feng Yang1, Yuting Huang2, Tian Li3, Yunting Fu4, Chenyu Sun5, Yecheng Xu6, John Windsor7, Deliang Fu6.   

Abstract

Entities:  

Keywords:  COVID-19; acute pancreatitis

Mesh：

Year:  2021        PMID： 34670809     DOI： 10.1136/gutjnl-2021-325941

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   31.793


× No keyword cloud information.
  5 in total

Review 1.  Review on acute pancreatitis attributed to COVID-19 infection.

Authors:  Takumi Onoyama; Hiroki Koda; Wataru Hamamoto; Shiho Kawahara; Yuri Sakamoto; Taro Yamashita; Hiroki Kurumi; Soichiro Kawata; Yohei Takeda; Kazuya Matsumoto; Hajime Isomoto
Journal:  World J Gastroenterol       Date:  2022-05-21       Impact factor: 5.374

2.  Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review.

Authors:  You Zhou; Yu-Tong Ge; Xiao-Xi Yang; Qian Cai; Yan-Bing Ding; Liang-Hao Hu; Guo-Tao Lu
Journal:  Front Public Health       Date:  2022-05-12

3.  Prevalence and prognosis of increased pancreatic enzymes in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Feng Yang; Yecheng Xu; Yinlei Dong; Yuting Huang; Yunting Fu; Tian Li; Chenyu Sun; Sanjay Pandanaboyana; John A Windsor; Deliang Fu
Journal:  Pancreatology       Date:  2022-03-25       Impact factor: 3.977

4.  Novel insight on marker genes and pathogenic peripheral neutrophil subtypes in acute pancreatitis.

Authors:  Deyu Zhang; Meiqi Wang; Yang Zhang; Chuanchao Xia; Lisi Peng; Keliang Li; Hua Yin; Shiyu Li; Xiaoli Yang; Xiaoju Su; Haojie Huang
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

5.  CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6.

Authors:  Peng Xu; XiaoLan Xu; Xiao Wu; LiXiang Zhang; Lei Meng; ZhangMing Chen; WenXiu Han; Jie Yao; AMan Xu
Journal:  Gastric Cancer       Date:  2021-07-22       Impact factor: 7.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.